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A B S T R A C T
Objective: Syntax score (SX) has emerged as a reproducible angiographic tool to quantify the extent of
coronary artery disease based on location and complexity of each lesion. It has been shown to predict
long-term clinical outcomes in patients with left main or multi-vessel disease and recently also in ST-
segment elevation myocardial infarction undergoing primary PCI. The aim of this study was to evaluate
whether the syntax score is associated with short-term cardiovascular outcomes in patients treated with
primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction
(STEMI).
Methods: Syntax score was determined in 90 consecutive patients (mean age 54.2  11.6) of STEMI
undergoing primary PCI. Outcomes were stratiﬁed according to syntax score groups: SX low 15 (n = 33), SX
mid 16–22 (n = 30), and SX high 23 (n = 27). The primary endpoint was all-cause mortality at 30 days.
Secondary endpoints were nonfatal major adverse cardiac and cerebrovascular events (MACE) deﬁned as a
composite of any repeat revascularization, acute coronary syndrome, and stroke at 30 days in patients
discharged alive.
Results: Mortality at 30 days was higher in the SX high group compared to the SX mid and SX low group
(18.5% vs 3.3% p = 0.011), MACE at 30 days was higher in SX high group compared to SX mid and SX low
group (48.1% vs 16.6% vs 9.1%, p = 0.001).
Conclusions: The syntax score is associated with 30-day mortality in patients with STEMI undergoing
primary PCI. In those discharged, it is associated with risk of MACE at 30 days.
 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Acute treatment of ST elevation myocardial infarction (STEMI)
is restoration of myocardial perfusion by recanalization of the
occluded vessel. Early reperfusion is associated with better
outcomes. Thus primary percutaneous coronary intervention
(PCI) has become the treatment of choice for acute STEMI. Most
scoring systems such as TIMI, GRACE that predict adverse events in
patients with acute coronary syndrome (ACS) rely on clinical
variables such as age, heart rate, blood pressure, Killip class, ST-
segment changes, and serum creatinine levels, while not taking
into account the characteristics of coronary lesions.1–4
The SYNTAX (Synergy between Percutaneous Coronary Inter-
vention with TAXUS and Cardiac Surgery) score (SX) has been
developed as a comprehensive angiographic scoring tool for
quantiﬁcation of coronary lesions with respect to their number,
location, and complexity. It was initially tested in patients with
stable coronary artery disease, multi-vessel disease or complexE-mail address: drsaritachoudhary@yahoo.com.
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licenses/by-nc-nd/4.0/).coronary lesions allocated to PCI or coronary artery bypass graft
(CABG) surgery in the landmark SYNTAX trial.5–8 Subsequently,
this score was also validated for left main disease and in all-comers
population undergoing PCI.9,10 It is a good predictor of adverse
cardiovascular events including cardiac death, myocardial infarc-
tion (MI), and target lesion revascularisation.9,11,12 Recently, it has
also validated for risk stratiﬁcation in STEMI undergoing primary
PCI, where it was found associated with mortality, major adverse
cardiac events, and stent thrombosis at 1-year follow-up.11
Previous studies using the syntax score have focused on long-
term clinical outcomes after PCI and data on its impact on short-
term outcome is limited. Thus, we determined the association of
syntax scores with short-term outcomes in patients with STEMI
undergoing primary PCI.
2. Methods
2.1. Study population
All patients who were admitted at our institution with STEMI
and underwent primary PCI during January 2014 to Januarytax score with short-term outcomes among acute ST-elevation
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54.2  11.6 years). None of these patients had been treated with
ﬁbrinolytic therapy. Performa has been designed to collect informa-
tion regarding age, gender, history of risk factors, diabetes,
dyslipidemia, hypertension, smoking, and family history of prema-
ture coronary artery disease (CAD). Patient’s clinical parameters, left
ventricular function, and killip class were recorded. Laboratory data
including hemoglobin, total leukocyte count, platelet count, creati-
nine, and cardiac enzymes, etc. were noted. Clinical characteristics at
baseline are shown in Table 1. Pre-treatment with drugs according to
standard guidelines was initiated. Urgent diagnostic coronary
angiography followed by primary PCI was performed. All primary
PCI procedures were performed by experienced interventional
cardiologists using femoral approach. The decision to perform PCI
and to implant bare-metal or drug-eluting stents was at the discretion
of the operator. Current guidelines for the management of STEMI
indicate that culprit-only intervention should be performed acutely
during primary PCI in the absence of cardiogenic shock and thus, it
was followed at our institution. Pre-dilatation or post-dilatation after
stent implantation, thrombosuction, use of eptiﬁbatide was at the
operator’s choice. There was no restriction on the type, length or
number of implanted stents. Baseline lesion and procedure char-
acteristics are listed in Table 2. Exclusion criteria were previous CABG
surgery or PCI and if emergent CABG surgery indication was present.
2.2. Determination of Syntax score
The Syntax score was calculated from baseline angiograms, for
all coronary lesions with a diameter stenosis greater than 50% in
vessels larger than 1.5 mm, using syntax score online calculator. AllTable 1
Baseline characteristics of patients according to syntax score (SXS).
Variables N = 90 (%) SX low
n = 33 (37
Number N = 90 n = 33 
Age, year 54.2 51.3 (12
Gender
Male 70 (77.8%) 28 (84.8%
Female 20 (22.2%) 5 (15.2%) 
Risk factors
Tobacco use 49 (54.4%) 17 (51.5%
Hypertension 39 (43.3%) 15 (45.4%
Diabetes 24 (26.7%) 6 (18.2%) 
Hyperlipidemia 20 (22.2%) 7 (21.1%) 
F/H CAD 14 (15.5%) 5 (15.1%) 
Clinical proﬁle
SBP, mm Hg 120.6 126.3 (1
Heart rate 75.4 72.4 (11
Killip class 2 13 (14.4%) 2 (6.1%) 
Creatinine (mg/dL) 1.1 1.0 (0.24
Ejection fraction (%) 42.3 45.5 ( 6
Time symptom onset to hospital [min] 211 218 
Door to balloon time [min] 82 74 
Total ischemic time (TIT) 293 292 (14
Type of STEM
AWMI 49 (54.4%) 15 (45.4%
IWMI  RV/PWMI 32 (35.6%) 13 (39.4%
Others 9 (10%) 5 (15.2%) 
In-hospital medication
Aspirin 90 (100%) 33 (100%)
Clopidogrel/prasugrel 90 (100%) 33 (100%)
Beta blockers 70 (77.8%) 25 (75.7%
ACE inhibitors/ARB 80 (88.9%) 31 (93.9%
Statins 90 (100%) 33 (100%)
Inotropic drugs 10 (11.1%) 1 (3.0%) 
Diuretics 9 (10%) 2 (6.1%) 
GPIIbIIIa inhibitors 43 (47.8%) 15 (45.5%
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by two independent investigators who were blinded to all clinical
data. If the infarct-related artery was occluded, it was scored as an
occluded artery of <3-month duration.
2.3. Study endpoints
The study’s primary endpoint was mortality at 30-day follow-
up. Secondary endpoints were nonfatal major adverse cardiac and
cerebrovascular events (MACE) deﬁned as a composite of any
repeat revascularization, acute coronary syndrome and stroke
within 30-day follow-up period in discharged patients. Any repeat
revascularization was deﬁned as repeat PCI or bypass grafting of
both infarct related artery and non-infarct related artery, driven by
ischemic symptoms.
2.4. Statistical methods
Continuous variables are expressed as mean and standard
deviation. Categorical variables are expressed as percentage. The
difference in means would be analyzed using student’s ‘t’ test. A
two-sided p < 0.05 was considered as statistically signiﬁcant. The
difference is categorical variables were analyzed using Chi-square
test.
3. Results
Out of 90 patients undergoing primary PCI for STEMI during
2014–2015, mean syntax score was 17.4 (range 6–46). Groups
were computed as SX low 15 (n = 33), SX mid 16–22 (n = 30), and%)
SX mid
n = 30 (33%)
SX high
n = 27 (30%)
p value
n = 30 n = 27
.74) 55.9 (11.04) 55.7 (10.73) 0.213
) 22 (73.3%) 20 (74.1%) 0.47
8 (26.7%) 7 (25.9%)
) 17 (56.7%) 15 (55.5%) 0.911
) 12 (40%) 12 (44.4%) 0.9
8 (26.7%) 10 (37%) 0.259
7 (23.3%) 6 (22.2%) 0.98
5 (16.7%) 4 (14.8%) 0.978
7.40) 124.8 (13.89) 110.6(13.47) 0
.3) 73.1 (11.62) 80.8 (14.7) 0.023
5 (16.6%) 6 (22.2%) 0.19
) 1.1 (0.36) 1.2 (0.49) 0.118
.90) 41.8 (6.96) 39.07 (7.08) 0.002
195 221
89 82
4.6) 284 (144) 303 (155.4) 0.887
) 15 (50%) 19 (70.4%) 0.263
) 13 (43.3%) 6 (22.2%)
2 (6.7%) 2 (7.4%)
 30 (100%) 27 (100%) 1
 30 (100%) 27 (100%) 1
) 25 (83.3%) 20 (74.1%) 0.661
) 27 (90%) 22 (81.5%) 0.303
 30 (100%) 27 (100%) 1
3 (10%) 6 (22.2%) 0.061
3 (10%) 4 (14.8%) 0.531
) 14 (46.7%) 14 (51.8%) 0.876
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Table 2
Basline lesion and procedural characteristics.
Variables N = 90 (%) SX low
n = 33 (%)
SX mid
n = 30 (%)
SX high
n = 27 (%)
p value
SX score 17.4 9.9 18.4 23.9
IRA 0.012
Left anterior descending 40 (44.4%) 8 (24.2%) 13 (43.3%) 19 (70.4%)
Circumﬂex artery 15 (16.7%) 8 (24.2%) 5 (16.7%) 2 (7.4%)
Right coronary artery 35 (38.9%) 17 (51.6%) 12 (40%) 6 (22.2%)
Left main disease 1 (1.1%) 0 1 (3.3%) 0 0.044
Number of diseased vessels 0.044
SVD 42 (46.7%) 20 (60.6%) 13 (43.3%) 9 (33.3%)
DVD 30 (33.3%) 11 (33.3%) 11 (36.7%) 8 (29.6%)
TVD 18 (20%) 2 (6.1%) 6 (20%) 10 (37.1%)
Total occlusion with thrombus 81 (90%) 29 (87.9%) 27 (90%) 25 (92.6%) 0.833
Total no. of stents implanted 1.3 1.1 (0.28) 1.3 (0.45) 1.6 (0.48) 0
Stent type
BMS 19 (21.1%) 7 (21.2%) 7 (23.3%) 5 (18.5%) 0.906
DES 71 (78.9%) 26 (78.8%) 23 (76.7%) 22 (81.5%)
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acteristics of patients are presented in Table 1. Mean age, gender,
baseline investigations, and risk factor proﬁle – hypertension,
dyslipidemia, smoking, diabetes, and family history of CAD were
similar between the three groups. At presentation, patients in SX
high group had higher heart rate (80.8 vs 73.1 vs 72.4, p = 0.02) and
lower systolic blood pressure (110.6 vs 124.8 vs 126.3, p < 0.001)
than SX mid and SX low groups. Left ventricular ejection fraction
(mean) was lower in patients with high syntax score compared to
those with mid-low scores (39.07% vs 41.8% vs 45.5%, p = 0.002).
Killips class, total ischemic time, type of STEMI, and in hospital
treatment did not differ between the groups.
There were higher rates of left anterior descending as the culprit
vessel in SX high group (70.4% vs 43.3% vs 24.25, p = 0.012). Triple
vessel disease (37.1% vs 20% vs 6.1%, p = 0.014) and number of
stents implanted (1.6 vs 1.3 vs 1.1, p < 0.001) were higher in SX
high group than SX low and mid groups.
3.1. Outcomes at 30-day follow-up
Six patients died within 30 days of the procedure (4 during
hospitalization and 2 after discharge) and 21 MACCE were
recorded during this period (Table 3).
4. Discussion
Syntax score is an important determinant of treatment decision
making in stable patients with left main or multi-vessel disease
undergoing elective PCI or CABG surgery and is validated to predict
the outcomes in these patients. The Syntax score was recently
validated in patients with STEMI undergoing primary PCI. The ﬁrst
dedicated analysis of the this score in patients with STEMI,
published by Garg et al. in 2011, showed that this score is aTable 3
Clinical outcome at 30 days.
Variables N = 90 (%) SX low
n = 33 (%)
All cause mortality 6 (6.7%) 0 
Cardiac death 5 (5.5%) 0 
Any repeat revascularization 8 (8.9%) 1 (3%) 
Acute coronary syndrome 10 (11.1%) 1 (3%) 
Cerebrovascular events 3 (3.3%) 1 (3%) 
Rehospitalization 15 (16.7%) 2 (6.1%) 
Overall MACE 21 (23.3%) 3 (9.1%) 
Please cite this article in press as: Choudhary S. Association of syn
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thrombosis at 1-year follow up.15
In this study, rates of all cause mortality were higher in patients
of SX high group than SX mid group (18.5% vs 3.3%, respectively
p = 0.01). Six patients died during hospitalization and follow up
period. One of them had acute renal failure due to contrast-induced
nephropathy. Four of them were caused by either cardiogenic
shock or acute pulmonary edema. One patient with anterior wall
STEMI, in SX mid group developed acute pancreatitis with multi-
organ dysfunction during hospitalization and died later. Previous
studies in patients undergoing primary PCI have also reported
syntax score as an independent predictor of mortality.5,8,11,15 Our
study shows that patients in the SX high group had a higher
prevalence of triple vessel disease compared with those in the SX
mid and low. The well-established association between multi-
vessel disease and cardiogenic shock may partly explain the
increase in the peri-procedural risk and high mortality.11,14 In
addition, as shown in our study, patients with high syntax score
had greater systolic dysfunction (lower LVEF) and greater LAD
occlusion, so they had greater area of myocardium involvement,
which may partly explain bad outcome in this group.11 Previous
studies have shown syntax score as a predictor for TIMI ﬂow grade
<3 and no reﬂow, which are associated with bad outcome.19,20
Biondi-Zoccai et al. showed in a meta-analysis that patients of
STEMI with multi-vessel disease have worse clinical outcomes
than those with single-vessel disease.12 Likewise, Brown et al.
showed that lesion complexity was predictive of mortality at a
follow-up of 2 years.13 This observation presumably reﬂects the
predominant role of anatomic complexity of coronary lesions in
determining mortality.
MACE were more common in patients with SX high group
compared to SX mid and SX low group (48.1% vs 16.6% vs 9.1%,
p = 0.001). In our study patients with high syntax score had higher
rates of any repeat revascularization than those with intermediateSX mid
n = 30 (%)
SX high
n = 27 (%)
p value
1 (3.3%) 5 (18.5%) 0.01
0 5 (18.5%) 0
1 (3.3%) 6 (22.2%) 0.01
3 (10%) 6 (22.2%) 0.06
1 (3.3%) 1 (3.7%) 0.99
5 (16.7%) 8 (29.6%) 0.05
5 (16.6%) 13 (48.1%) 0
tax score with short-term outcomes among acute ST-elevation
 J. (2016), http://dx.doi.org/10.1016/j.ihj.2016.08.002
S. Choudhary / Indian Heart Journal xxx (2016) xxx–xxx4
G Model
IHJ-1029; No. of Pages 4and low score (22.2% vs 3.3% vs 3%, p = 0.014). Since patients in SX
high group had more multi-vessel disease or complex lesions, not
opening the non-culprit lesions during the initial procedure may
partly explain these ﬁndings. But our study followed PCI of infarct
related artery in the light of current ACC/AHA STEMI guidelines.17
Recently, the Preventive Angioplasty in Acute Myocardial Infarc-
tion study reported that the primary outcome of cardiac death, MI,
or refractory angina was signiﬁcantly less common in the
preventive-PCI group, as compared with optimal medical therapy
alone.18 Therefore, the best strategy for staged revascularization in
STEMI with MVD is yet to be clariﬁed further. Similarly, Sorajja
et al. reported that multi-vessel disease was associated with a
higher rate of revascularization in patients with STEMI after
primary PCI.16 Thus, a high syntax score was found to be associated
with re-infarction and need for revascularization.
Occurrence of cerebrovascular events did not differ between
the three groups.
The present study shows that the high Syntax score is
associated with mortality and MACE at 30 days in patients with
STEMI undergoing primary PCI. These results are in agreement
with recent studies showing that the syntax score has risk
predictive value both in patients undergoing elective PCI and in
those undergoing primary PCI for STEMI.
4.1. Study limitations
Number of patients in our study group was less, but it was
sufﬁcient to reach statistically signiﬁcant results and conclusions
particularly with respect to 30-day mortality.
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